Drosha-dependent microRNAs modulate FUS-mediated neurodegeneration in vivo
Nucleic Acids Research · 10.11.2023 · 51 (20) · 11258-11276
DOI: 10.1093/nar/gkad774 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 04.10.2023. Verfasst von Sukhleen Kour und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA 15224, USA. Hauptthemen laut MEDLINE: MicroRNAs, Heterogeneous-Nuclear Ribonucleoprotein Group F-H, Ribonuclease III, Drosophila Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
Mutations in the Fused in Sarcoma (FUS) gene cause the familial and progressive form of amyotrophic lateral sclerosis (ALS). FUS is a nuclear RNA-binding protein involved in RNA processing and the biogenesis of a specific set of microRNAs. Here we report that Drosha and two previously uncharacterized Drosha-dependent miRNAs are strong modulators of FUS expression and prevent the cytoplasmic segregation of insoluble mutant FUS in vivo. We demonstrate that depletion of Drosha mitigates FUS-mediated degeneration, survival and motor defects in Drosophila. Mutant FUS strongly interacts with Drosha and causes its cytoplasmic mis-localization into the insoluble FUS inclusions. Reduction in Drosha levels increases the solubility of mutant FUS. Interestingly, we found two Drosha dependent microRNAs, miR-378i and miR-6832–5p, which differentially regulate the expression, solubility and cytoplasmic aggregation of mutant FUS in iPSC neurons and mammalian cells. More importantly, we report different modes of action of these miRNAs against mutant FUS. Whereas miR-378i may regulate mutant FUS inclusions by preventing G3BP-mediated stress granule formation, miR-6832–5p may affect FUS expression via other proteins or pathways. Overall, our research reveals a possible association between ALS-linked FUS mutations and the Drosha-dependent miRNA regulatory circuit, as well as a useful perspective on potential ALS treatment via microRNAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA 15224, USA.
- Center for Regenerative Therapies TU Dresden (CRTD), Technische Universität (TU) Dresden, Dresden, 01307, Germany.
- Department of Pediatrics, Division of Health Informatics, Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA.
- Medical Faculty Carl Gustav Carus of TU Dresden, Dresden, 01307, Germany.
- Children's Neuroscience Institute, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA 15224, USA.
ORCID-Profile: Udai Bhan Pandey
Förderung
- NINDS NIH HHS
- NIH HHS
- NIH
- HTC cluster from the University of Pittsburgh Center for Research Computing
Zitieren
APA
Kour, S., Fortuna, T., Anderson, E. N., Mawrie, D., Bilstein, J., Sivasubramanian, R., Ward, C., Roy, R., Rajasundaram, D., Sterneckert, J., & Pandey, U. B. (2023). Drosha-dependent microRNAs modulate FUS-mediated neurodegeneration in vivo. Nucleic Acids Research, 51(20), 11258-11276. https://doi.org/10.1093/nar/gkad774
Vancouver
Kour S, Fortuna T, Anderson EN, Mawrie D, Bilstein J, Sivasubramanian R, et al. Drosha-dependent microRNAs modulate FUS-mediated neurodegeneration in vivo. Nucleic Acids Research. 2023;51(20):11258-11276. doi:10.1093/nar/gkad774
BibTeX
@article{Kour2023,
author = {Kour, Sukhleen and Fortuna, Tyler and Anderson, Eric N and Mawrie, Darilang and Bilstein, Jessica and Sivasubramanian, Ramakrishnan and Ward, Caroline and Roy, Rishit and Rajasundaram, Dhivyaa and Sterneckert, Jared and Pandey, Udai Bhan},
title = {Drosha-dependent microRNAs modulate FUS-mediated neurodegeneration in vivo},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {20},
pages = {11258--11276},
doi = {10.1093/nar/gkad774}
}
EUVIMED